[Theoretical and practical problems raised by the methodology of long-acting neuroleptics in man].
Explore the source record for details and available documents.
Adult↗
Biomedical subjects
J Fermanian
Publications and source records attributed to J Fermanian.
Lung function after neonatal respiratory distress syndrome.
Functional residual capacity (FRC), dynamic lung compliance (CLdyn) and lung resistance (RL) were measured in a group of 51 healthy children aged 18 months to 6 years (group A) and in a group of 69 survivors of the respiratory distress syndrome (RDS) of the same age (group B). Forty-four per cent of the latter had clinical and radiological abnormalities. In the healthy children significant correlations were found between FRC and height (p less than 0.01), CLdyn and height (P less than 0.01) and CLdyn and FRC (p less than 0.01) but a poor correlation existed between RL and height (p greater than 0.05). There was no significant difference between groups A and B in the slopes of the regression lines for FRC, CLdyn and RL against height, but the intercept for the regression lines relating to CLdyn and RL was lower in group B than in group A. Group B was divided into two subgroups according to the length of exposure to artificial ventilation with an FIO2 in excess of 60 %. A lower value for CLdyn was found in the sub-group with the longer exposure (greater than 120 hours) to a high FIO2, suggesting that this is an additional factor in causing lung damage.
Airway Obstruction↗
An acellular vaccine from Pseudomonas aeruginosa: homologous and crossed protection between serogroups according to Habs' classification.
Homologous and cross-reactions were studied in 16 strains of Pseudomonas aeruginosa belonging to different O serogroups according to Habs' classification. By slide agglutination, cross-reactions were rare between the strains of two or three serogroups: O2, O5 and O16; O1 and O9; O7 and O8; O13 and O14. Experiments of cross-protection have been performed in mice inoculated with acellular vaccines prepared from the 16 studied strains. A high homologous protection was observed with all the 16 strains, which is in favour of existence of an O serogroup-specific immunity. However, it exists some cross-protective reactions between the serogroups. This cross-protection allows to reduce the numbers of strains for a polyvalent vaccine. A classification of P. aeruginosa into 8 classes of related serogroups (A to H) is proposed which could be a basis for an antigenic classification of P. aeruginosa.
Agglutination Tests↗